Skip to main content
Caplight Logo









BioOrbit

BioOrbit

Private
LondonHealthcare & Life Scienceshttps://bioorbit.space/

Last Round

Seed

Apr 30, 2026

Total Funding Raised

$29.28M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

BioOrbit is a biotechnology company that operates a pharmaceutical factory for the large-scale crystallization of protein drugs in microgravity.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Space Technology, Biotech Equipment, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts, Hardware Sales

AI Layer

Non-AI

Keywords

microgravity manufacturingContract Development and Manufacturing OrganisationCDMOin-orbit manufacturingdrug reformulationspace manufacturingin-space manufacturingspace pharmaprotein crystallizationsubcutaneous drug deliverybiologics manufacturingspace biotechIV to SC conversionspace factorymonoclonal antibodiesspace hardware

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BioOrbit Comparables

Compare BioOrbit with similar companies based on industry and business-model similarity.

BioOrbit comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Space LiinTech
84%
Frontier Space Technologies
81%
SpacePharma
78%

BioOrbit Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedApr 30, 2026
SeedApr 30, 2026
GrantFeb 9, 2026

Key People

Founding team and executive leadership

Katie King

CEO And Co-Founder

Founding Team

Jacques Fossey

Chief Technology Officer

Executive Team

BioOrbit Investors

Notable investors and investment history

BioOrbit investors
InvestorRounds
7 Percent VenturesSeed, Pre Seed
BreegaSeed
Phoenix Court GroupSeed
Type One VenturesSeed, Pre Seed
UK Space AgencyGrant
SeedcampSeed, Pre Seed
AuxxoSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 7, 2026

    Open roles increased to 9, double the trailing average.

  • Aug 3, 2026

    Open roles increased to 8, 3.3x the trailing average.

BioOrbit Filings

Explore SEC and related filing metadata, where available.

BioOrbit filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about BioOrbit's valuation, stock price, and market status.

Is BioOrbit a public or private company?

BioOrbit is a private company.

What is the current stock price of BioOrbit?

BioOrbit is a private company with no public stock price. No recent secondary market data is available.

How much is BioOrbit worth (valuation)?

Valuation information for BioOrbit is not publicly available.

Can I buy BioOrbit stock?

BioOrbit shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was BioOrbit's last funding round?

BioOrbit's most recent funding round was Seed on April 30, 2026.

Who are the main investors in BioOrbit?

Key investors in BioOrbit include Breega, Phoenix Court Group.

Will BioOrbit IPO soon?

No public IPO plans have been announced for BioOrbit.

How can I track BioOrbit secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BioOrbit's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range19
Year Founded2023
Last FundingApr 30, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?